Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Unadjusted cumulative cardiovascular and overall mortality according to YKL-40 levels and UACR above and below median at baseline in a representative group of the general population without diabetes, hypertension or CVD

From: YKL-40 - an emerging biomarker in cardiovascular disease and diabetes

  Cardiovascular mortality*, % Overall mortality*, %
YKL-40 < median, UACR ≤ median 0.7 4.4
YKL-40 > median, UACR ≤ median 1.1 8.0
YKL-40 ≤ median, UACR > median 3.0 7.6
YKL-40 > median, UACR > median 10.6 30.6
  1. *p < 0.0001 for all comparisons.
  2. N = 389, cardiovascular mortality events = 13, overall mortality events = 44.
  3. Median value of YKL-40, 59.5 ng/ml, median value of UACR, 7 mg/g.
  4. Abbreviation: UACR, urinany albumin/creatinine ratio.